Konstantinos Soureas

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Targeting Collagens and LOX Through Plant-Derived MicroRNAs (XenomiRs).

Targeting Collagens and LOX Through Plant-Derived MicroRNAs (XenomiRs).

Journal: Methods in molecular biology (Clifton, N.J.)

Published: September 02, 2026

Liquid biopsy miRNA risk score in bladder cancer: Translational insights from patient-derived xenografts to prognostic stratification.

Liquid biopsy miRNA risk score in bladder cancer: Translational insights from patient-derived xenografts to prognostic stratification.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 24, 2026

Delving into tRNA-derived small RNAs in multiple myeloma: elevated 3'U-tRFSerTGA leads to poor disease prognosis.

Delving into tRNA-derived small RNAs in multiple myeloma: elevated 3'U-tRFSerTGA leads to poor disease prognosis.

Journal: British journal of cancer

Published: September 16, 2025

Identification of Oncogene-Induced Senescence-Associated MicroRNAs.

Identification of Oncogene-Induced Senescence-Associated MicroRNAs.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 14, 2025

Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients.

Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients.

Journal: International journal of cancer

Published: February 05, 2025

Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome.

Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome.

Journal: Blood cancer journal

Published: October 31, 2024

Exploring the methyl-verse: Dynamic interplay of epigenome and m6A epitranscriptome.

Exploring the methyl-verse: Dynamic interplay of epigenome and m6A epitranscriptome.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 23, 2024

Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRFHisGTG results in patients' poor treatment outcome.

Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRFHisGTG results in patients' poor treatment outcome.

Journal: British journal of haematology

Published: October 19, 2023

Cancer quiescence: non-coding RNAs in the spotlight.

Cancer quiescence: non-coding RNAs in the spotlight.

Journal: Trends in molecular medicine

Published: May 14, 2023

Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform.

Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform.

Journal: International journal of molecular sciences

Published: April 13, 2023

miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma.

miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma.

Journal: Journal of translational medicine

Published: January 19, 2023

Showing 1-11 of 11

Last Updated: 09/26/2026